{"id":388415,"date":"2020-11-25T08:03:21","date_gmt":"2020-11-25T13:03:21","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=388415"},"modified":"2020-11-25T08:03:21","modified_gmt":"2020-11-25T13:03:21","slug":"enzo-biochem-announces-appointment-of-ian-b-walters-md-to-its-board-of-directors","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-announces-appointment-of-ian-b-walters-md-to-its-board-of-directors\/","title":{"rendered":"ENZO BIOCHEM ANNOUNCES APPOINTMENT OF IAN B. WALTERS, MD, TO ITS BOARD OF DIRECTORS"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">NEW YORK, NY, Nov.  25, 2020  (GLOBE NEWSWIRE) &#8212; Enzo Biochem, Inc. (NYSE:ENZ) (\u201cEnzo\u201d or \u201cThe Company\u201d), a leading biosciences and diagnostics company, announced today that Ian B. Walters, MD, has been appointed to the Company\u2019s Board of Directors effective immediately.\u00a0 \u00a0\u00a0<\/p>\n<p align=\"justify\">Dr. Walters is an experienced entrepreneur and drug developer with leadership in the development of over 30 drugs in multiple therapeutic areas involving diverse technologies, leading to five new oncology drug approvals. His previous positions include Executive Director of Global Oncology Clinical Research and Business Development for Bristol-Myers Squibb, and Medical Director at Millennium Pharmaceuticals. Dr. Walters currently is CEO and Director of Portage Biotech, a publicly traded clinical stage biopharmaceutical company developing an innovative portfolio of immuno-oncology assets. He is also founder of seven of Portage\u2019s portfolio companies.<\/p>\n<p align=\"justify\">Dr. Walters holds an MBA from the Wharton School of the University of Pennsylvania. He received his MD at the Albert Einstein College of Medicine and completed doctoral training in experimental medicine at The Rockefeller University.\u00a0 Dr. Walters has been the lead author or contributor to approximately 60 journal publications.<\/p>\n<p align=\"justify\">\u201cDr. Walters brings over two decades of diverse experience in drug development and business strategy, including both founding and executive level positions at several life sciences companies,\u201d said Dr. Elazar Rabbani, Ph.D., Enzo\u2019s Chairman and Chief Executive Officer.\u00a0 \u201cAs a physician, scientist and entrepreneur, his deep expertise spans clinical development, regulatory affairs, and strategic planning. \u00a0At a time when we have announced promising growth and continued momentum going into 2021, Dr. Walters will play an integral role in identifying new ways Enzo\u2019s offerings can effectively support companion diagnostics, early drug discovery, and liquid biopsy techniques.\u201d<\/p>\n<p align=\"justify\">\u00a0\u201cEnzo continues to demonstrate its role as an innovative leader through its rapid response to the COVID-19 pandemic and continued implementation of cost effective, adaptive technologies to address key challenges in the clinical diagnostics industry,\u201d said Dr. Walters. \u00a0\u201cI am eager to work together with the other members of the board and Enzo\u2019s management team to assure its future success and target new opportunities for growth.\u201d <\/p>\n<p>\n        <strong><br \/>\n          <u>About Enzo Biochem<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p>Enzo Biochem is a pioneer in molecular diagnostics, leading the convergence of clinical laboratories, life sciences and intellectual property through the development of unique diagnostic platform technologies that provide numerous advantages over previous standards. A global company, Enzo Biochem utilizes cross-functional teams to develop and deploy products, systems and services that meet the ever-changing and rapidly growing needs of health care today and into the future. Underpinning Enzo Biochem\u2019s products and technologies is a broad and deep intellectual property portfolio, with patent coverage across a number of key enabling technologies. For additional information please visit: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rX-jvjBjkKgNro5-9m9CALxO2NsmPyFxIQSVbaLDY-zDXjT4IvM0PtK57z8oBhGL57r1ZlpgmEQ2hPeD21PSyA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>http:\/\/www.enzo.com\/<\/u><\/a><strong><u><br \/><\/u><\/strong><\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <u>Forward-Looking Statements<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"justify\">Except for historical information, the matters discussed in this release may be considered &#8220;forward-looking&#8221; statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include declarations regarding the intent, belief or current expectations of the Company and its management, including those related to cash flow, gross margins, revenues, and expenses which are dependent on a number of factors outside of the control of the Company including, inter alia, the markets for the Company\u2019s products and services, costs of goods and services, other expenses, government regulations, litigation, and general business conditions. See Risk Factors in the Company\u2019s Form 10-K for the fiscal year ended July 31, 2020. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve a number of risks and uncertainties that could materially affect actual results. The Company disclaims any obligations to update any forward-looking statement as a result of developments occurring after the date of this release.<\/p>\n<p align=\"center\">###<\/p>\n<p align=\"left\">\n        <br \/>\n        <strong>Contacts<\/strong>:<\/p>\n<p>David Bench, CFO<br \/> Enzo Biochem, Inc.<br \/> 212-583-0100<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8a1JydieQ5xP7EqvqJB4v_GKSQwOcGZaHZryMTFqpfnLygfK7xLnYGa8mh2_M5d0SgsMXp00nYdOlYw5aDyWEg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>dbench@enzo.com<\/u><\/a><\/p>\n<p>\n        <strong>Media: <\/strong>\n      <\/p>\n<p>Marisa Monte\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<br \/>Berry &amp; Company Public Relations<br \/>212-253-8881<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=LivHNoxGdicCpoFWzydVL1VYs1zbKFGi_cZu5WANEkqc0-M0sJFTRef6jG3Qk0ysQVzjH2N7jqpWuhDBxwbBeMaYfvd8p6z3XoWA-E1sCmE=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>mmonte@berrypr.com<\/u><\/a><\/p>\n<p>\n        <strong>Investors<\/strong>:<\/p>\n<p>Jeremy Feffer<br \/>LifeSci Advisors, LLC<br \/>212-915-2568<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=A9qCf6Wn-nPfJVXTmoCJByyD4W0yRX2vTIeqwaDGwbuBsRtzmmhDXqC7zGv7-KPtyYu1UpJFpNiB6Esl9P2poX5k2vmxE9cqAqj6Wp9xViW3faJFY-W84wYfIvRrUU2S\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>jeremy@lifesciadvisors.com<\/u><\/a><\/p>\n<p>Steve Anreder<br \/>Anreder &amp; Company<br \/>212-532-3232<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6BIzh94dKMPGVdC5QSgIZri6T7uQvZ9MBkxGjcsNUNn8w5wVPocqmJdCDVHgfMHVo9Mx9I-F3wFM4MTziJlS2-DP4Ci163zyRDE-SVKYwf9uEQfsHhrABiBQbEb1d5v-\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>Steven.anreder@anreder.com<\/u><\/a><\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MTk0MyMzODQzMTc3IzUwMDA3MTYzNQ==\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/d80571c9-2191-4de1-8675-9f7637504206\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, NY, Nov. 25, 2020 (GLOBE NEWSWIRE) &#8212; Enzo Biochem, Inc. (NYSE:ENZ) (\u201cEnzo\u201d or \u201cThe Company\u201d), a leading biosciences and diagnostics company, announced today that Ian B. Walters, MD, has been appointed to the Company\u2019s Board of Directors effective immediately.\u00a0 \u00a0\u00a0 Dr. Walters is an experienced entrepreneur and drug developer with leadership in the development of over 30 drugs in multiple therapeutic areas involving diverse technologies, leading to five new oncology drug approvals. His previous positions include Executive Director of Global Oncology Clinical Research and Business Development for Bristol-Myers Squibb, and Medical Director at Millennium Pharmaceuticals. Dr. Walters currently is CEO and Director of Portage Biotech, a publicly traded clinical stage biopharmaceutical company developing an innovative portfolio of immuno-oncology &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-announces-appointment-of-ian-b-walters-md-to-its-board-of-directors\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ENZO BIOCHEM ANNOUNCES APPOINTMENT OF IAN B. WALTERS, MD, TO ITS BOARD OF DIRECTORS&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-388415","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ENZO BIOCHEM ANNOUNCES APPOINTMENT OF IAN B. WALTERS, MD, TO ITS BOARD OF DIRECTORS - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-announces-appointment-of-ian-b-walters-md-to-its-board-of-directors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ENZO BIOCHEM ANNOUNCES APPOINTMENT OF IAN B. WALTERS, MD, TO ITS BOARD OF DIRECTORS - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, NY, Nov. 25, 2020 (GLOBE NEWSWIRE) &#8212; Enzo Biochem, Inc. (NYSE:ENZ) (\u201cEnzo\u201d or \u201cThe Company\u201d), a leading biosciences and diagnostics company, announced today that Ian B. Walters, MD, has been appointed to the Company\u2019s Board of Directors effective immediately.\u00a0 \u00a0\u00a0 Dr. Walters is an experienced entrepreneur and drug developer with leadership in the development of over 30 drugs in multiple therapeutic areas involving diverse technologies, leading to five new oncology drug approvals. His previous positions include Executive Director of Global Oncology Clinical Research and Business Development for Bristol-Myers Squibb, and Medical Director at Millennium Pharmaceuticals. Dr. Walters currently is CEO and Director of Portage Biotech, a publicly traded clinical stage biopharmaceutical company developing an innovative portfolio of immuno-oncology &hellip; Continue reading &quot;ENZO BIOCHEM ANNOUNCES APPOINTMENT OF IAN B. WALTERS, MD, TO ITS BOARD OF DIRECTORS&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-announces-appointment-of-ian-b-walters-md-to-its-board-of-directors\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-25T13:03:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MTk0MyMzODQzMTc3IzUwMDA3MTYzNQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enzo-biochem-announces-appointment-of-ian-b-walters-md-to-its-board-of-directors\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enzo-biochem-announces-appointment-of-ian-b-walters-md-to-its-board-of-directors\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ENZO BIOCHEM ANNOUNCES APPOINTMENT OF IAN B. WALTERS, MD, TO ITS BOARD OF DIRECTORS\",\"datePublished\":\"2020-11-25T13:03:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enzo-biochem-announces-appointment-of-ian-b-walters-md-to-its-board-of-directors\\\/\"},\"wordCount\":680,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enzo-biochem-announces-appointment-of-ian-b-walters-md-to-its-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MTk0MyMzODQzMTc3IzUwMDA3MTYzNQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enzo-biochem-announces-appointment-of-ian-b-walters-md-to-its-board-of-directors\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enzo-biochem-announces-appointment-of-ian-b-walters-md-to-its-board-of-directors\\\/\",\"name\":\"ENZO BIOCHEM ANNOUNCES APPOINTMENT OF IAN B. WALTERS, MD, TO ITS BOARD OF DIRECTORS - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enzo-biochem-announces-appointment-of-ian-b-walters-md-to-its-board-of-directors\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enzo-biochem-announces-appointment-of-ian-b-walters-md-to-its-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MTk0MyMzODQzMTc3IzUwMDA3MTYzNQ==\",\"datePublished\":\"2020-11-25T13:03:21+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enzo-biochem-announces-appointment-of-ian-b-walters-md-to-its-board-of-directors\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enzo-biochem-announces-appointment-of-ian-b-walters-md-to-its-board-of-directors\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enzo-biochem-announces-appointment-of-ian-b-walters-md-to-its-board-of-directors\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MTk0MyMzODQzMTc3IzUwMDA3MTYzNQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MTk0MyMzODQzMTc3IzUwMDA3MTYzNQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enzo-biochem-announces-appointment-of-ian-b-walters-md-to-its-board-of-directors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ENZO BIOCHEM ANNOUNCES APPOINTMENT OF IAN B. WALTERS, MD, TO ITS BOARD OF DIRECTORS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ENZO BIOCHEM ANNOUNCES APPOINTMENT OF IAN B. WALTERS, MD, TO ITS BOARD OF DIRECTORS - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-announces-appointment-of-ian-b-walters-md-to-its-board-of-directors\/","og_locale":"en_US","og_type":"article","og_title":"ENZO BIOCHEM ANNOUNCES APPOINTMENT OF IAN B. WALTERS, MD, TO ITS BOARD OF DIRECTORS - Market Newsdesk","og_description":"NEW YORK, NY, Nov. 25, 2020 (GLOBE NEWSWIRE) &#8212; Enzo Biochem, Inc. (NYSE:ENZ) (\u201cEnzo\u201d or \u201cThe Company\u201d), a leading biosciences and diagnostics company, announced today that Ian B. Walters, MD, has been appointed to the Company\u2019s Board of Directors effective immediately.\u00a0 \u00a0\u00a0 Dr. Walters is an experienced entrepreneur and drug developer with leadership in the development of over 30 drugs in multiple therapeutic areas involving diverse technologies, leading to five new oncology drug approvals. His previous positions include Executive Director of Global Oncology Clinical Research and Business Development for Bristol-Myers Squibb, and Medical Director at Millennium Pharmaceuticals. Dr. Walters currently is CEO and Director of Portage Biotech, a publicly traded clinical stage biopharmaceutical company developing an innovative portfolio of immuno-oncology &hellip; Continue reading \"ENZO BIOCHEM ANNOUNCES APPOINTMENT OF IAN B. WALTERS, MD, TO ITS BOARD OF DIRECTORS\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-announces-appointment-of-ian-b-walters-md-to-its-board-of-directors\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-25T13:03:21+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MTk0MyMzODQzMTc3IzUwMDA3MTYzNQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-announces-appointment-of-ian-b-walters-md-to-its-board-of-directors\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-announces-appointment-of-ian-b-walters-md-to-its-board-of-directors\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ENZO BIOCHEM ANNOUNCES APPOINTMENT OF IAN B. WALTERS, MD, TO ITS BOARD OF DIRECTORS","datePublished":"2020-11-25T13:03:21+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-announces-appointment-of-ian-b-walters-md-to-its-board-of-directors\/"},"wordCount":680,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-announces-appointment-of-ian-b-walters-md-to-its-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MTk0MyMzODQzMTc3IzUwMDA3MTYzNQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-announces-appointment-of-ian-b-walters-md-to-its-board-of-directors\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-announces-appointment-of-ian-b-walters-md-to-its-board-of-directors\/","name":"ENZO BIOCHEM ANNOUNCES APPOINTMENT OF IAN B. WALTERS, MD, TO ITS BOARD OF DIRECTORS - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-announces-appointment-of-ian-b-walters-md-to-its-board-of-directors\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-announces-appointment-of-ian-b-walters-md-to-its-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MTk0MyMzODQzMTc3IzUwMDA3MTYzNQ==","datePublished":"2020-11-25T13:03:21+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-announces-appointment-of-ian-b-walters-md-to-its-board-of-directors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-announces-appointment-of-ian-b-walters-md-to-its-board-of-directors\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-announces-appointment-of-ian-b-walters-md-to-its-board-of-directors\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MTk0MyMzODQzMTc3IzUwMDA3MTYzNQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MTk0MyMzODQzMTc3IzUwMDA3MTYzNQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-announces-appointment-of-ian-b-walters-md-to-its-board-of-directors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ENZO BIOCHEM ANNOUNCES APPOINTMENT OF IAN B. WALTERS, MD, TO ITS BOARD OF DIRECTORS"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/388415","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=388415"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/388415\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=388415"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=388415"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=388415"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}